Science news

The firm will develop viral vector vaccines from IAVI and Themis Bioscience, and the experimental EIDD-2801 antiviral compound developed by Ridgeback Biotherapeutics
Submissions to the new journal will open this summer
Achievement paves the way to a better understanding of carbohydrate structures and functions
Once thought to boost levels of ACE2, the novel coronavirus's doorway into human cells, these widely used medicines are now contenders to treat the respiratory disease
New instruments come online with improved resolution, broadening applications for the technique
The firm says its experimental mRNA vaccine is safe and induced promising levels of antibodies in a small Phase I clinical trial
Developed by – «Panther Web Solutions»